Phase I study of F16IL2 antibody-cytokine fusion with very low-dose araC in acute myeloid leukaemia relapse after allogeneic stem cell transplantation.

Christoph SchliemannTorsten KesslerAndrew F BerdelTeresa HemmerleLinus AngenendtBianca AltvaterClaudia RossigJan-Henrik MikeschGeorg LenzMichael SchäfersDario NeriMatthias StelljesWolfgang E Berdel

Published in: British journal of haematology (2021)

Keyphrases

stem cell transplantation
high dose
low dose
liver failure
bone marrow
acute myeloid leukemia
respiratory failure
dendritic cells
drug induced
aortic dissection
extracorporeal membrane oxygenation